1. Home
  2. RCEL vs RDVT Comparison

RCEL vs RDVT Comparison

Compare RCEL & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • RDVT
  • Stock Information
  • Founded
  • RCEL 2020
  • RDVT 2017
  • Country
  • RCEL United States
  • RDVT United States
  • Employees
  • RCEL N/A
  • RDVT N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • RDVT Computer Software: Prepackaged Software
  • Sector
  • RCEL Health Care
  • RDVT Technology
  • Exchange
  • RCEL Nasdaq
  • RDVT Nasdaq
  • Market Cap
  • RCEL 342.7M
  • RDVT 396.7M
  • IPO Year
  • RCEL N/A
  • RDVT N/A
  • Fundamental
  • Price
  • RCEL $11.77
  • RDVT $37.81
  • Analyst Decision
  • RCEL Hold
  • RDVT Strong Buy
  • Analyst Count
  • RCEL 3
  • RDVT 1
  • Target Price
  • RCEL $16.50
  • RDVT $25.00
  • AVG Volume (30 Days)
  • RCEL 96.7K
  • RDVT 91.3K
  • Earning Date
  • RCEL 02-20-2025
  • RDVT 11-06-2024
  • Dividend Yield
  • RCEL N/A
  • RDVT N/A
  • EPS Growth
  • RCEL N/A
  • RDVT N/A
  • EPS
  • RCEL N/A
  • RDVT 0.36
  • Revenue
  • RCEL $60,040,000.00
  • RDVT $70,685,000.00
  • Revenue This Year
  • RCEL $40.34
  • RDVT $24.88
  • Revenue Next Year
  • RCEL $52.79
  • RDVT $14.52
  • P/E Ratio
  • RCEL N/A
  • RDVT $105.89
  • Revenue Growth
  • RCEL 32.24
  • RDVT 21.43
  • 52 Week Low
  • RCEL $7.51
  • RDVT $16.56
  • 52 Week High
  • RCEL $18.93
  • RDVT $39.88
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 43.48
  • RDVT 54.89
  • Support Level
  • RCEL $11.30
  • RDVT $37.19
  • Resistance Level
  • RCEL $12.75
  • RDVT $39.88
  • Average True Range (ATR)
  • RCEL 0.74
  • RDVT 1.76
  • MACD
  • RCEL -0.24
  • RDVT -0.32
  • Stochastic Oscillator
  • RCEL 18.01
  • RDVT 45.81

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About RDVT Red Violet Inc.

Red Violet Inc is a software and services company. It specializes in big data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses, and assets.

Share on Social Networks: